feed,title,long_url,short_url
BioRxiv,Emergence and expansion of highly infectious spike:D614G mutant SARS-CoV-2 in central India,https://biorxiv.org/cgi/content/short/2020.09.15.297846v1?rss=1,https://j.mp/33wzqW1
BioRxiv,"The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro",https://biorxiv.org/cgi/content/short/2020.09.15.296228v1?rss=1,https://j.mp/33sI8oe
BioRxiv,"Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo",https://biorxiv.org/cgi/content/short/2020.09.15.298067v1?rss=1,https://j.mp/33vNhMl
BioRxiv,Ceftazidime Is a Potential Drug to Inhibit SARS-CoV-2 Infection In Vitro by Blocking Spike Protein-ACE2 Interaction,https://biorxiv.org/cgi/content/short/2020.09.14.295956v1?rss=1,https://j.mp/2Rs7Wvf
BioRxiv,Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy,https://biorxiv.org/cgi/content/short/2020.09.15.298547v1?rss=1,https://j.mp/3hEF3Gx
